Eminence Capital’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,137,358
Closed -$175M 57
2018
Q4
$175M Sell
3,137,358
-5,284
-0.2% -$287K 3.4% 9
2018
Q3
$146M Buy
3,142,642
+407,354
+15% +$19.7M 2.4% 18
2018
Q2
$132M Buy
2,735,288
+18,293
+0.7% +$875K 1.8% 21
2018
Q1
$118M Sell
2,716,995
-168,320
-6% -$7.56M 1.75% 25
2017
Q4
$115M Sell
2,885,315
-19,644
-0.7% -$819K 1.75% 27
2017
Q3
$126M Sell
2,904,959
-372,690
-11% -$17M 2.04% 23
2017
Q2
$157M Sell
3,277,649
-21,995
-0.7% -$1.03M 2.67% 15
2017
Q1
$135M Buy
3,299,644
+1,815,270
+122% +$75.8M 2.43% 16
2016
Q4
$57M Buy
+1,484,374
New +$60.3M 0.89% 41

Eminence Capital's IMPV Position: Q1 2019 in Review

Eminence Capital sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 3,137,358 shares — an estimated $175M sold.

Eminence Capital first reported a position in IMPV in Q4 2016 and held it in 9 quarters. The position peaked at $175M in Q4 2018. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

  • Eminence Capital reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
  • Eminence Capital sold 3,137,358 Imperva, Inc. shares in Q1 2019, an estimated $175M.
  • Eminence Capital first reported a position in Imperva, Inc. in Q4 2016 and held it in 9 quarters.
  • Eminence Capital's Imperva, Inc. position peaked at $175M in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on Eminence Capital's 13F filing for Q1 2019, filed 15 May 2019.